Guangzhou Super-View Biotechnology Co., Ltd.

Guangzhou Super-View Biotechnology Co., Ltd. (abbreviated as "Super-View Technology"), originated from an interdisciplinary laboratory at Peking University, with its founding team comprising top experts in fields such as biological imaging and scientific exploration. The company was officially registered and established in 2019, and has successfully completed two rounds of financing exceeding 100 million yuan. Its headquarters is located in the Huangpu Laboratory Park, Huangpu District, Guangzhou, with over 100 employees and more than 4,500 square meters of R&D and office space. Equipped with advanced infrastructure, including cell culture operation laboratories, cell imaging laboratories, microscopy imaging technology R&D laboratories, and a 10,000-level cleanliness assembly line workshop, as well as a high-performance computing cluster dedicated to analyzing and managing PB-level live cell data, this highlights Super-View Technology's determination to forge ahead in the field of biomedical research, steadfastly committed to advancing scientific knowledge, exploring the limits of scientific research and medical care, and shaping the future of science and medicine. Super-View Technology's flagship product, HIS-SIM, is the world's pioneering instrument capable of achieving 60-nanometer ultra-high resolution at the live cell level, featuring multi-channel long-term simultaneous imaging capabilities, and continuously incorporating cutting-edge machine intelligence functions, thereby transforming and driving advances in key fields such as cell biology, virology, immunology, new drug development, and broader scientific and industrial applications. Super-View Technology remains dedicated to developing and providing cutting-edge technologies in optical imaging and data processing, aiming to empower researchers and end users, and promote the development of instruments that have significant impact on human health and well-being.